Literature DB >> 24096931

p53 talks to PARP: the increasing complexity of p53-induced cell death.

K G Wiman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24096931      PMCID： PMC3792432          DOI： 10.1038/cdd.2013.111

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  14 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 2.  Necrotic death as a cell fate.

Authors:  Wei-Xing Zong; Craig B Thompson
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

Review 3.  Transcription-independent pro-apoptotic functions of p53.

Authors:  Ute M Moll; Sonja Wolff; Daniel Speidel; Wolfgang Deppert
Journal:  Curr Opin Cell Biol       Date:  2005-10-13       Impact factor: 8.382

4.  Restoration of p53 function leads to tumour regression in vivo.

Authors:  Andrea Ventura; David G Kirsch; Margaret E McLaughlin; David A Tuveson; Jan Grimm; Laura Lintault; Jamie Newman; Elizabeth E Reczek; Ralph Weissleder; Tyler Jacks
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

5.  Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.

Authors:  Wen Xue; Lars Zender; Cornelius Miething; Ross A Dickins; Eva Hernando; Valery Krizhanovsky; Carlos Cordon-Cardo; Scott W Lowe
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

Review 6.  Poly(ADP-ribose): novel functions for an old molecule.

Authors:  Valérie Schreiber; Françoise Dantzer; Jean-Christophe Ame; Gilbert de Murcia
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

7.  Modeling the therapeutic efficacy of p53 restoration in tumors.

Authors:  Carla P Martins; Lamorna Brown-Swigart; Gerard I Evan
Journal:  Cell       Date:  2006-12-21       Impact factor: 41.582

Review 8.  TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.

Authors:  A Petitjean; M I W Achatz; A L Borresen-Dale; P Hainaut; M Olivier
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

9.  Alkylating DNA damage stimulates a regulated form of necrotic cell death.

Authors:  Wei-Xing Zong; Dara Ditsworth; Daniel E Bauer; Zhao-Qi Wang; Craig B Thompson
Journal:  Genes Dev       Date:  2004-05-14       Impact factor: 11.361

Review 10.  Shaping genetic alterations in human cancer: the p53 mutation paradigm.

Authors:  Thierry Soussi; Klas G Wiman
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743
View more
  12 in total

1.  Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Current-Based Quantitative Proteomics (IonStar).

Authors:  Xue Wang; Jin Niu; Jun Li; Xiaomeng Shen; Shichen Shen; Robert M Straubinger; Jun Qu
Journal:  Mol Cell Proteomics       Date:  2018-01-22       Impact factor: 5.911

2.  Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth.

Authors:  Yizheng Zhang; Chuchu Zhang; Jiehan Li; Meimei Jiang; Shuning Guo; Ge Yang; Lingling Zhang; Feng Wang; Shiqi Yi; Jiangang Wang; Yang Fu; Yingjie Zhang
Journal:  Cell Commun Signal       Date:  2022-06-17       Impact factor: 7.525

3.  Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.

Authors:  Giuseppe S Sica; Cristina Fiorani; Carmine Stolfi; Giovanni Monteleone; Eleonora Candi; Ivano Amelio; Valeria Catani; Simone Sibio; Andrea Divizia; Giorgia Tema; Edoardo Iaculli; Achille L Gaspari
Journal:  Oncotarget       Date:  2015-05-30

4.  TAp73 promotes anti-senescence-anabolism not proliferation.

Authors:  Massimiliano Agostini; Maria Victoria Niklison-Chirou; Maria Valeria Catani; Richard A Knight; Gerry Melino; Alessandro Rufini
Journal:  Aging (Albany NY)       Date:  2014-11       Impact factor: 5.682

5.  Bioinformatics analysis of the serine and glycine pathway in cancer cells.

Authors:  Alexey Antonov; Massimiliano Agostini; Maria Morello; Marilena Minieri; Gerry Melino; Ivano Amelio
Journal:  Oncotarget       Date:  2014-11-30

Review 6.  How Does p73 Cause Neuronal Defects?

Authors:  Maria Victoria Niklison-Chirou; Richard Killick; Richard A Knight; Pierluigi Nicotera; Gerry Melino; Massimiliano Agostini
Journal:  Mol Neurobiol       Date:  2015-08-13       Impact factor: 5.590

Review 7.  Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis.

Authors:  S Nicolai; M Pieraccioli; A Peschiaroli; G Melino; G Raschellà
Journal:  Cell Death Dis       Date:  2015-12-03       Impact factor: 8.469

Review 8.  Current Management Strategies in Breast Cancer by Targeting Key Altered Molecular Players.

Authors:  Shazia Ali; Neelima Mondal; Hani Choudhry; Mahmood Rasool; Peter N Pushparaj; Mohammad A Khan; Maryam Mahfooz; Ghufrana A Sami; Jummanah Jarullah; Ashraf Ali; Mohammad S Jamal
Journal:  Front Oncol       Date:  2016-03-01       Impact factor: 6.244

Review 9.  The multifaceted role of PARP1 in RNA biogenesis.

Authors:  Rebekah Eleazer; Yvonne N Fondufe-Mittendorf
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-07-12       Impact factor: 9.957

10.  Cancer-Related Intracellular Signalling Pathways Activated by DOXorubicin/Cyclodextrin-Graphene-Based Nanomaterials.

Authors:  Rosamaria Pennisi; Maria Musarra-Pizzo; Tania Velletri; Antonino Mazzaglia; Giulia Neri; Angela Scala; Anna Piperno; Maria Teresa Sciortino
Journal:  Biomolecules       Date:  2022-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.